Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.066 | 0.7 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |